These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding. Bispo M, Marcelino P, Marques HP, Martins A, Perdigoto R, Aguiar MJ, Mourão L, Barroso E. Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509 [Abstract] [Full Text] [Related]
28. Is the role of transjugular intrahepatic portosystemic shunts limited in the management of patients with end-stage liver disease? Forster J, Siegel EL, Delcore R, Payne KM, Laurin J, Kindscher JD. Am J Surg; 1996 Nov; 172(5):536-9; discussion 539-40. PubMed ID: 8942559 [Abstract] [Full Text] [Related]
29. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. D'Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI. Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469 [Abstract] [Full Text] [Related]
30. [First experience with transjugular intrahepatic porto-systemic shunt (TIPS)]. Lázár I, Petó J, Kristóf T. Magy Seb; 2002 Feb; 55(1):9-15. PubMed ID: 11930565 [Abstract] [Full Text] [Related]
31. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS]. Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V. Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599 [Abstract] [Full Text] [Related]
32. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Am J Gastroenterol; 2003 Dec; 98(12):2688-93. PubMed ID: 14687818 [Abstract] [Full Text] [Related]
33. Segmental liver ischemia/infarction after elective transjugular intrahepatic portosystemic shunt creation: clinical outcomes in 10 patients. Lopera JE, Katabathina V, Bosworth B, Garg D, Kroma G, Garza-Berlanga A, Suri R, Wholey M. J Vasc Interv Radiol; 2015 Jun; 26(6):835-41. PubMed ID: 25661437 [Abstract] [Full Text] [Related]
34. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA. J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064 [Abstract] [Full Text] [Related]
35. Transjugular intrahepatic portosystemic shunts in liver transplant recipients. Kim JJ, Dasika NL, Yu E, Fontana RJ. Liver Int; 2008 Feb; 28(2):240-8. PubMed ID: 18251981 [Abstract] [Full Text] [Related]
36. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome. Darwish Murad S, Luong TK, Pattynama PM, Hansen BE, van Buuren HR, Janssen HL. Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982 [Abstract] [Full Text] [Related]